Androgen Receptor Modulator Drug Could Improve Breast Cancer
University of Liverpool
Phase 2 trial results indicate benefits of the new way of treating advanced ER+ breast cancer
Innovative approach integrates genetic data to identify drug targets with high potential for clinical trial success